Pharmaceutical Executive Daily: Eli Lilly's $1.5 Billion Stockpile of Orforglipron
Feb 13, 2026
01:26
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
In today’s Pharmaceutical Executive Daily, Eli Lilly builds a $1.5 billion stockpile of Orforglipron ahead of an FDA decision, PTC Therapeutics withdraws and plans to resubmit its Translarna NDA, and a former AstraZeneca executive is charged with multiple offenses in China.
Pharmaceutical Executive